Display options
Share it on

Public Health Ethics. 2016 Jul;9(2):183-197. doi: 10.1093/phe/phw004. Epub 2016 Mar 14.

Lifestyle Vaccines and Public Health: Exploring Policy Options for a Vaccine to Stop Smoking.

Public health ethics

Anna Wolters, Guido de Wert, Onno C P van Schayck, Klasien Horstman

Affiliations

  1. Maastricht University, School CAPHRI, Department of Health, Ethics, and Society.
  2. Maastricht University, School CAPHRI, Department of General Practice.

PMID: 27551304 PMCID: PMC4985897 DOI: 10.1093/phe/phw004

Abstract

Experimental vaccines are being developed for the treatment of 'unhealthy lifestyles' and associated chronic illnesses. Policymakers and other stakeholders will have to deal with the ethical issues that this innovation path raises: are there morally justified reasons to integrate these innovative biotechnologies in future health policies? Should public money be invested in further research? Focusing on the case of an experimental nicotine vaccine, this article explores the ethical aspects of 'lifestyle vaccines' for public health. Based on findings from a qualitative study into a vaccine for smoking cessation, the article articulates possible value conflicts related to nicotine vaccination as an intervention in tobacco control. The 'vaccinization' of lifestyle disease piggybacks on the achievements of classic vaccines. Contrary to expectations of simplicity and success, quitting smoking with a vaccine requires a complex supportive network. Social justice and public trust may become important ethical challenges when deciding whether to use further public funds for research or whether to implement these innovative vaccines in the future.

References

  1. Addiction. 2012 Apr;107(4):801-9 - PubMed
  2. Addiction. 2014 Sep;109(9):1414-25 - PubMed
  3. Pharmacol Ther. 2005 Oct;108(1):76-85 - PubMed
  4. Hastings Cent Rep. 2013 May-Jun;43(3):34-5 - PubMed
  5. Tob Control. 2014 Nov;23(e2):e133-8 - PubMed
  6. Soc Sci Q. 2012 Dec 1;92(5):1363-1388 - PubMed
  7. Soc Sci Med. 2012 Sep;75(5):775-83 - PubMed
  8. Nicotine Tob Res. 2012 Jan;14(1):75-8 - PubMed
  9. Bioethics. 2005 Feb;19(1):49-71 - PubMed
  10. Hastings Cent Rep. 2013 May-Jun;43(3):23-33 - PubMed
  11. Tob Control. 2015 Jul;24(4):336-40 - PubMed
  12. PLoS One. 2008 Sep 09;3(9):e3163 - PubMed
  13. Tob Control. 2013 May;22 Suppl 1:i31-2 - PubMed
  14. Med Soc (Berkeley). 1996;:1-466 - PubMed
  15. Addiction. 2014 Aug;109(8):1252-9 - PubMed
  16. Lancet. 2006 Jul 29;368(9533):341-2 - PubMed
  17. Cochrane Database Syst Rev. 2012 Aug 15;(8):CD007072 - PubMed
  18. BMC Public Health. 2010 Apr 27;10:211 - PubMed
  19. Ther Adv Chronic Dis. 2010 May;1(3):95-106 - PubMed
  20. Am J Public Health. 2012 Nov;102(11):2013-8 - PubMed
  21. JAMA. 2014 Jan 8;311(2):183-92 - PubMed
  22. Tob Control. 2014 Nov;23(e2):e89-97 - PubMed
  23. Lancet. 1971 Feb 27;1(7696):405-12 - PubMed
  24. Clin Pharmacol Ther. 2011 Mar;89(3):392-9 - PubMed
  25. Lancet. 2002 Oct 5;360(9339):1089-91 - PubMed
  26. Sociol Health Illn. 2010 Sep;32(6):914-29 - PubMed
  27. Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2815-22 - PubMed
  28. Soc Sci Med. 2014 Mar;104:116-23 - PubMed
  29. J Med Ethics. 2004 Aug;30(4):344-5 - PubMed
  30. Public Health Ethics. 2013 Jul;6(2):197-206 - PubMed
  31. Eur J Public Health. 2014 Aug;24(4):551-6 - PubMed
  32. Curr Opin Psychiatry. 2011 May;24(3):191-6 - PubMed
  33. Soc Sci Med. 2012 Mar;74(5):767-74 - PubMed
  34. Nicotine Tob Res. 2013 Sep;15(9):1492-501 - PubMed
  35. Nat Rev Immunol. 2011 Dec 16;12 (1):67-72 - PubMed
  36. Soc Sci Med. 2013 Dec;98:264-70 - PubMed
  37. Sociol Health Illn. 2014 Feb;36(2):199-212 - PubMed
  38. Soc Sci Med. 1975 Feb;9(2):83-7 - PubMed
  39. J Epidemiol Community Health. 2006 Nov;60(11):998-1003 - PubMed
  40. Addiction. 2012 Nov;107(11):2029-36 - PubMed
  41. Drugs. 2012 Mar 5;72(4):e1-16 - PubMed
  42. Tob Control. 2015 Sep;24(5):455-61 - PubMed
  43. PLoS Med. 2010 Feb 09;7(2):e1000216 - PubMed
  44. Tob Control. 2009 Feb;18(1):43-6 - PubMed
  45. Tob Control. 2016 Jul;25(4):470-5 - PubMed
  46. Addiction. 2014 Mar;109(3):491-9 - PubMed
  47. N Engl J Med. 2004 Aug 26;351(9):927-32 - PubMed
  48. Bioethics. 2013 Jun;27(5):271-9 - PubMed
  49. Soc Sci Med. 2014 Jan;101:155-65 - PubMed
  50. CNS Drugs. 2001;15(7):505-14 - PubMed
  51. Addiction. 2014 Oct;109(10):1750-9 - PubMed
  52. Cochrane Database Syst Rev. 2012 Oct 17;10:CD008286 - PubMed
  53. Soc Sci Med. 2009 Dec;69(12):1784-90 - PubMed
  54. Bioethics. 2009 Feb;23(2):79-89 - PubMed
  55. JAMA. 2014 Jan 8;311(2):193-4 - PubMed
  56. Hum Vaccin. 2009 Apr;5(4):200-5 - PubMed
  57. BMC Public Health. 2012 Dec 06;12:1052 - PubMed
  58. J Law Med Ethics. 2012 Spring;40(1):85-98 - PubMed
  59. Addiction. 2014 Aug;109(8):1268-73 - PubMed
  60. Addiction. 2014 Jul;109(7):1049-51 - PubMed
  61. Nicotine Tob Res. 2014 Jun;16(6):725-32 - PubMed
  62. Bull World Health Organ. 2012 Mar 1;90(3):241-2 - PubMed
  63. Tob Control. 2014 Nov;23(e2):e122-6 - PubMed
  64. Ann N Y Acad Sci. 2012 Feb;1248:107-23 - PubMed
  65. Soc Sci Med. 2008 Aug;67(3):463-72 - PubMed
  66. Addiction. 2010 Nov;105(11):1867-9 - PubMed

Publication Types